NIPT
NIPT
NIPT (Non-Invasive Prenatal Test)
Non-invasive prenatal testing (NIPT) is a safe and highly accurate genetic screening test performed by analyzing cell-free fetal DNA circulating in the mother´s blood. This test can be performed from the 10th week of pregnancy and is highly effective in assessing the risk of chromosomal abnormalities such as Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), and Patau syndrome (Trisomy 13).
As a non-invasive method, it is preferred as an alternative screening test to procedures like amniocentesis or chorionic villus sampling. NIPT can be recommended in cases of advanced maternal age, a history of chromosomal abnormalities in previous pregnancies, high-risk results from conventional screening tests, or simply upon request. It is a modern, safe, and early diagnostic tool that provides valuable information during pregnancy follow-up.